title: IL-1beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells.
abstract: IL-1beta increased the production of proenzyme of MMP-9 (pro-MMP-9) in a time- and dose-dependent manner in murine macrophage RAW 264.7 cells. However, the production of MMP-2 was not significantly changed by IL-1beta treatment. The intracellular H(2)O(2) content, as determined with H(2)O(2)-sensitive probe 2('),7(')-dichlorodihydrofluorescein, also increased after IL-1beta treatment (5ng/ml). In addition, exogenous H(2)O(2) (50 microM) was found to increase the production of pro-MMP-9. Transient transfection study using a MMP-9 promoter-reporter construct showed that IL-1beta enhanced the MMP-9 promoter activity. Electrophoretic mobility shift assay and site-directed mutagenesis study on the consensus binding site for NF-kappaB revealed that the activation of NF-kappaB is required for the IL-1beta-induced activation of MMP-9 promoter. N-acetylcysteine, an antioxidant, could abrogate the production of pro-MMP-9, H(2)O(2) generation, and activation of NF-kappaB and MMP-9 promoter. These results suggest that IL-1beta upregulates the MMP-9 expression via production of reactive oxygen species and activation of NF-kappaB in RAW 264.7 cells.
authors.affiliation: Chonnam National University Research Institute of Medical Sciences, Chonnam National University Medical School, Kwangju 501-190, Republic of Korea.
authors.forename: Hyeon G
authors.initials: HG
authors.lastname: Yoo
authors.forename: Boo A
authors.initials: BA
authors.lastname: Shin
authors.forename: Jung S
authors.initials: JS
authors.lastname: Park
authors.forename: Kee H
authors.initials: KH
authors.lastname: Lee
authors.forename: Kee O
authors.initials: KO
authors.lastname: Chay
authors.forename: Sung Y
authors.initials: SY
authors.lastname: Yang
authors.forename: Bong W
authors.initials: BW
authors.lastname: Ahn
authors.forename: Young D
authors.initials: YD
authors.lastname: Jung
mesh_terms: D000818:Animals; D002460:Cell Line; D017364:Collagenases / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004792:Enzyme Precursors / Q000378:metabolism; D007375:Interleukin-1 / Q000494:pharmacology*; D007700:Kinetics; D008264:Macrophages / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D016328:NF-kappa B / Q000502:physiology*; D011401:Promoter Regions, Genetic; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015533:Transcriptional Activation; D015854:Up-Regulation
chemical_list: D004792:Enzyme Precursors; D007375:Interleukin-1; D016328:NF-kappa B; D017382:Reactive Oxygen Species; D017364:Collagenases; C120487:pro-matrix metalloproteinase 9; D020780:Matrix Metalloproteinase 9